2BB score and signals
Nuvectis Pharma, Inc.’s current 2BB score is 10 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 16 | Very Low |
| Momentum | 61 | Improving |
| Financial strength | 23 | Weak |
| Quality | 40 | Normal |
| Risk | 68 | High |
Company facts
| Headquarters | Fort Lee, New Jersey, United States |
| Founded | 2020 |
| Employees | 16 |
| 52-week range | $5.55 – $29.28 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-09 | — | -0.2584 | — | $0.00 |
| 2026-11-02 | — | -0.2465 | — | $0.00 |
| 2026-08-11 | — | -0.2672 | — | $0.00 |
| 2026-05-05 | -0.26 | -0.3162 | $0.00 | $0.00 |
Related companies
